[Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
Starting from the structural analogy between bromo-ergocryptine (Parlodel) and dihydroergocryptine caffeine (Vasobral), as well as with dihydroergotoxine (Hydergine), the authors decided to test the efficacy of the last two products in inhibiting post-partum physiological milk secretion. Twelve patients will be treated with either one of the two products, with a clinical and biological efficacy (serum prolactin level assay) which is comparable to that found in the literature regarding Parlodel. This study confirm the results obtained in a study of the inhibition of hyper-prolactinemia of other origin, by the same authors.
Elsener
M
M
Clinique Mutualiste des Eaux Claires de Grenoble.
Ferrafiat
M
M
de Bruyn
M
M
Jouhet
P
P
Robert
Y
Y
Rouge
P E
PE
D000328:Adult; D001940:Breast / Q000473:pathology; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D049590:Postpartum Period; D011247:Pregnancy; D011388:Prolactin / Q000097:blood
D004088:Dihydroergotoxine; D011388:Prolactin
Inhibition de la sécrétion lactée physiologique du post-partum par la dihydro-ergokryptine caféine et la dihydro-ergotoxine.